Become a Better Investor
587 FOLLOWERS
Become a Better Investor.net is run by investors for investors and was founded by the team behind A. Stotz Investment Research (ASIR). At ASIR we live by a motto to "Never stop learning" and we want to share this learning about investments with you.
Become a Better Investor
17h ago
The post Become a Better Investor Newsletter – 4 May 2024 appeared first on Become a Better Investor.
Noteworthy this week
Only one cut by the Fed in 2024
60/40 is not as safe as you may think
US accounts for 25% of global GDP
Replace nuclear with coal
The copper opportunity
Only one cut by the Fed in 2024: Prediction markets now show a 36% chance of ZERO interest rate cuts in 2024. The base case has gone from 6 rate cuts to 1 rate cut this year.
You can’t make this up:
Prediction markets now show a 36% chance of ZERO interest rate cuts in 2024, according to @Kalshi.
To put this in perspect ..read more
Become a Better Investor
2d ago
The post Goal Setting Is Often An Act of Desperation: Part 3 appeared first on Become a Better Investor.
The post was originally published here.
Goal Setting Is Often An Act of Desperation: Part 3
“In part 3 of this series, John Dues and host Andrew Stotz talk about the final 5 lessons for data analysis in education. Dive into this discussion to learn more about why data analysis is essential and how to do it right.”
Get the full show notes here.
Listen on Apple Podcasts or Google Podcasts.
Read more articles like this on Become a ..read more
Become a Better Investor
3d ago
The post Tyson Foods – World Class Benchmarking appeared first on Become a Better Investor.
Company: Tyson Foods Incorporated
Bloomberg ticker: TSN US
Market cap: US$19,029m
Background: Tyson Foods Incorporated is an American multinational corporation based in Springdale, Arkansas that operates in the food industry. The company is the world’s second-largest processor and marketer of chicken, beef, and pork after JBS S.A. It annually exports the largest percentage of beef out of the United States.
World Class Benchmarking of Tyson Foods
Profitable Growth rank of 9 was down compared to ..read more
Become a Better Investor
5d ago
The post Nike – World Class Benchmarking appeared first on Become a Better Investor.
Company: Nike Incorporated
Bloomberg ticker: NKE US
Market cap: US$147,921m
Background: Nike Incorporated is engaged in the designing, marketing and distributing of athletic footwear, apparel, equipment and accessories and services for sports and fitness activities. It sells a line of equipment and accessories under the NIKE Brand name, including bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment and other equipment designed for sports activities. It also designs ..read more
Become a Better Investor
6d ago
The post Adidas – World Class Benchmarking appeared first on Become a Better Investor.
Company: Adidas AG
Bloomberg ticker: ADS GR
Market cap: US$36,335m
Background: Adidas AG is a Germany-based company that designs, develops, produces and markets a range of athletic and sports lifestyle products. The Company has over 2,500 own-retail stores, mono-branded franchise stores, shop-in-shops, joint ventures with retail partners and co-branded stores and an e-commerce channel, which is available to customers in over 50 countries. The adidas branded products include footwear, apparel and hardware, su ..read more
Become a Better Investor
1w ago
The post Become a Better Investor Newsletter – 27 April 2024 appeared first on Become a Better Investor.
Noteworthy this week
Bonds only diversify under low inflation
Japanese earnings almost 2x the US
The MMT inflation train
Central banks load up on gold
AI demands power
Bonds only diversify under low inflation: Bonds are a good hedge for stock investors only if core inflation is predictably below 3%.
Bonds are a good hedge for stock investors only if core inflation is predictably below 3%.
Otherwise they suck at diversifying portfolios. pic.twitter.com/EyWuZTT74U
— Alf (@MacroAlf) April 2 ..read more
Become a Better Investor
1w ago
The post Johnson & Johnson – World Class Benchmarking appeared first on Become a Better Investor.
Company: Johnson & Johnson
Bloomberg ticker: JNJ US
Market cap: US$383,813m
Background: Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being.
World Class Benchmarking of Johnson & Johnson
Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank
This is World Class performan ..read more
Become a Better Investor
1w ago
The post Sinovac Biotech – World Class Benchmarking appeared first on Become a Better Investor.
Company: Sinovac Biotech Limited
Bloomberg ticker: SVA US
Market cap: US$640m
Background: Sinovac Biotech Limited is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases
World Class Benchmarking of Sinovac Biotech
Profitable Growth rank of 8 was same compared to the prior period’s 8th rank
This is below average performance compared to 400 medium ..read more
Become a Better Investor
1w ago
The post Pfizer – World Class Benchmarking appeared first on Become a Better Investor.
Company: Pfizer Incorporated
Bloomberg ticker: PFE US
Market cap: US$153,536m
Background: Pfizer Incorporated is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide.
World Class Benchmarking of Pfizer
Profitable Growth rank of 5 was down compared to the prior period’s 1st rank
This is average performance compared to 380 large Health Care companies worldwide
Profi ..read more
Become a Better Investor
1w ago
The post AstraZeneca – World Class Benchmarking appeared first on Become a Better Investor.
Company: AstraZeneca PLC
Bloomberg ticker: AZN LN
Market cap: US$200,088m
Background: AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology.
World Class Benchmarking of AstraZeneca
Profitable Growth rank of 4 was down compared to the prior period’s 3rd rank
Thi ..read more